Avalyn Pharma Inc (AVLN)

Avalyn Pharma Inc experienced significant insider activity on May 1, 2026, when multiple entities and individuals executed substantial purchase orders. SR One Capital Management, Novo Holdings, and Jill Carroll collectively acquired over 1.3 million shares. These transactions represent the most recent recorded trading events for the firm, occurring more than three months ago.
Ticker: AVLN Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.3
Novo Holdings A/S Large shareholder
Transaction date
Purchase
Price
121.37
Quantity 55,432 +22.4%
Value US$530,390
3.4
Carroll Jill Non-Executive Director
Transaction date
Purchase
Price
143.51
Quantity 19,977 -9.8%
Value US$3,200,752
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-05 2026-05-01 B Purchase Large shareholder
55,432 +22.4%
121.37
US$530,390
55,432 +22.4% 121.37 US$530,390
2026-05-01 2026-05-01 B Purchase Non-Executive Director
19,977 -9.8%
143.51
US$3,200,752
19,977 -9.8% 143.51 US$3,200,752
2026-05-01 2026-05-01 B Purchase Large shareholder
61,796 +36.5%
378.27
US$1,613,353
61,796 +36.5% 378.27 US$1,613,353
2026-05-01 2026-05-01 B Purchase Large shareholder
277,778 +14.6%
18.00
US$5,000,004
277,778 +14.6% 18.00 US$5,000,004